Literature DB >> 33730587

A short isoform of STIM1 confers frequency-dependent synaptic enhancement.

Girish Ramesh1, Lukas Jarzembowski1, Yvonne Schwarz2, Vanessa Poth1, Maik Konrad1, Mona L Knapp1, Gertrud Schwär3, Anna A Lauer4, Marcus O W Grimm4, Dalia Alansary1, Dieter Bruns2, Barbara A Niemeyer5.   

Abstract

Store-operated Ca2+-entry (SOCE) regulates basal and receptor-triggered Ca2+ signaling with STIM proteins sensing the endoplasmic reticulum (ER) Ca2+ content and triggering Ca2+ entry by gating Orai channels. Although crucial for immune cells, STIM1's role in neuronal Ca2+ homeostasis is controversial. Here, we characterize a splice variant, STIM1B, which shows exclusive neuronal expression and protein content surpassing conventional STIM1 in cerebellum and of significant abundance in other brain regions. STIM1B expression results in a truncated protein with slower kinetics of ER-plasma membrane (PM) cluster formation and ICRAC, as well as reduced inactivation. In primary wild-type neurons, STIM1B is targeted by its spliced-in domain B to presynaptic sites where it converts classic synaptic depression into Ca2+- and Orai-dependent short-term synaptic enhancement (STE) at high-frequency stimulation (HFS). In conjunction with altered STIM1 splicing in human Alzheimer disease, our findings highlight STIM1 splicing as an important regulator of neuronal calcium homeostasis and of synaptic plasticity.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CICR; ICRAC; Orai; SOCE; endocytosis; localization; presynaptic ER; short-term enhancement; vesicles

Mesh:

Substances:

Year:  2021        PMID: 33730587     DOI: 10.1016/j.celrep.2021.108844

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  8 in total

Review 1.  STIM and Orai Mediated Regulation of Calcium Signaling in Age-Related Diseases.

Authors:  Helen E Collins; Dingguo Zhang; John C Chatham
Journal:  Front Aging       Date:  2022-04-19

Review 2.  Role of the endoplasmic reticulum in synaptic transmission.

Authors:  Natali L Chanaday; Ege T Kavalali
Journal:  Curr Opin Neurobiol       Date:  2022-04-05       Impact factor: 7.070

Review 3.  Plasma Membrane and Organellar Targets of STIM1 for Intracellular Calcium Handling in Health and Neurodegenerative Diseases.

Authors:  Valentina Tedeschi; Daniele La Russa; Cristina Franco; Antonio Vinciguerra; Diana Amantea; Agnese Secondo
Journal:  Cells       Date:  2021-09-23       Impact factor: 6.600

Review 4.  Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.

Authors:  Daniela Rossi; Maria Rosaria Catallo; Enrico Pierantozzi; Vincenzo Sorrentino
Journal:  J Gen Physiol       Date:  2022-08-18       Impact factor: 4.000

5.  Store-operated calcium entry is reduced in spastin-linked hereditary spastic paraplegia.

Authors:  Tania Rizo; Lisa Gebhardt; Julia Riedlberger; Esther Eberhardt; Lars Fester; Dalia Alansary; Jürgen Winkler; Soeren Turan; Philipp Arnold; Barbara A Niemeyer; Michael J M Fischer; Beate Winner
Journal:  Brain       Date:  2022-09-14       Impact factor: 15.255

6.  Plasma Membrane Calcium ATPase Regulates Stoichiometry of CD4+ T-Cell Compartments.

Authors:  Maylin Merino-Wong; Barbara A Niemeyer; Dalia Alansary
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 7.  Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension.

Authors:  Bastien Masson; David Montani; Marc Humbert; Véronique Capuano; Fabrice Antigny
Journal:  Biomolecules       Date:  2021-11-27

8.  A longer isoform of Stim1 is a negative SOCE regulator but increases cAMP-modulated NFAT signaling.

Authors:  Mona L Knapp; Dalia Alansary; Vanessa Poth; Kathrin Förderer; Frederik Sommer; David Zimmer; Yvonne Schwarz; Nicolas Künzel; Achim Kless; Khaled Machaca; Volkhard Helms; Timo Mühlhaus; Michael Schroda; Annette Lis; Barbara A Niemeyer
Journal:  EMBO Rep       Date:  2021-12-23       Impact factor: 8.807

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.